1-8 of 8
Frank E. Shafer, MD
Close
Sort by
Journal Articles

Dose Selection Process for Younger Children Participating in a Phase 3 Study to Evaluate the Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Patients with Sickle Cell Disease

Brinda Tammara, PhD, Frank E. Shafer, MD, Lutz Harnisch, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3643.
https://doi.org/10.1182/blood-2018-99-117550
Published: 2018
Journal Articles

Effect of Renal Impairment on the Pharmacokinetics and Safety of Rivipansel in Subjects with Renal Impairment and in Healthy Subjects

Brinda Tammara, PhD, Kelly Ryan, Anna Plotka, Frank E. Shafer, MD, Hua Wei, David Readett, Annie Fang, Joan Korth-Bradley, PharmD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1083.
https://doi.org/10.1182/blood-2018-99-111926
Published: 2018
Journal Articles

Nonacog Alfa: Analysis Of Safety Data From 6 Prospective Clinical Studies In Different Patient Populations With Hemophilia B Treated With Different Therapeutic Modalities

Pablo Rendo, MD, Lynne Smith, MBA, Lee Hsiao-Yu, Frank E. Shafer, MD
Journal: Blood
Blood (2013) 122 (21): 3604.
https://doi.org/10.1182/blood.V122.21.3604.3604
Published: 2013
Journal Articles

Identification and Characterization of Clinical, Humanistic and Economic Outcomes and Clinical Endpoints in Vaso Occlusive Crisis of Sickle Cell Disease – A Systematic Review

Jigar Rajpura, Joseph Thomas, Frank E. Shafer, MD, Krupa M. Sivamurthy, MBBS, MD, Carl Kollmer, Nicholas Vendetti, MS
Journal: Blood
Blood (2012) 120 (21): 4710.
https://doi.org/10.1182/blood.V120.21.4710.4710
Published: 2012
Journal Articles

Evaluation of Two Secondary Prophylaxis Regimens of Recombinant Factor IX(r-IX) in Moderately Severe to Severe( FIX ≤2%) Hemophilia B Patients

Pablo Rendo, MD, Mary-Kate Barrette-Grischow, MA, MPH, Lynne Smith, MBA, JM Korth-Bradley, Robert Charnigo, Frank E. Shafer, MD
Journal: Blood
Blood (2012) 120 (21): 4628.
https://doi.org/10.1182/blood.V120.21.4628.4628
Published: 2012
Journal Articles

Health Outcomes in Vaso Occlusive Crisis of Sickle Cell Disease - Retrospective Indicators

Jigar Rajpura, Frank E. Shafer, MD, Krupa M. Sivamurthy, MBBS, MD, Carl Kollmer, Nicholas Vendetti, MS
Journal: Blood
Blood (2012) 120 (21): 4699.
https://doi.org/10.1182/blood.V120.21.4699.4699
Published: 2012
Journal Articles

Lack of Seasonal Variation in Bleeding and Patient-Assessed Pain Patterns in Patients with Hemophilia B Receiving On-Demand Therapy

Frank E. Shafer, MD, Lynne Smith, MBA, Nicholas Vendetti, MS, Pablo Rendo, MD, Marcus E. Carr, MD
Journal: Blood
Blood (2012) 120 (21): 1136.
https://doi.org/10.1182/blood.V120.21.1136.1136
Published: 2012
Journal Articles

Pharmacokinetic/Pharmacodynamic Assessment of Reformulated Recombinant Coagulation Factor IX in Adults and Children with Severe Hemophilia B

JM Korth-Bradley, Leonard A. Valentino, MD, FAAP, Pablo Rendo, MD, Frank E. Shafer, MD, Lynne Smith, James A. Baumann, Robert Charnigo
Journal: Blood
Blood (2011) 118 (21): 1190.
https://doi.org/10.1182/blood.V118.21.1190.1190
Published: 2011